There are 3161 resources available
Latest data in the 1L ALK+ aNSCLC treatment landscape
Presenter: Justin Gainor
Session: Pfizer Oncology - Setting a new benchmark for ALK+ aNSCLC targeted therapy
Resources:
Webcast
Emerging targeted therapies in lung cancers of neuroendocrine origin: DLL3
Presenter: Martin Wermke
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast
Role of Long-term Efficacy, Safety Outcomes and Different Routes of Administration in the Advance Disease Setting: the RCC Experience
Presenter: Laurence Albiges
Session: Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC
Resources:
Webcast
National implementation of Liquid Biopsy testing for Non Small Cell Lung Cancer – QuicDNA
Presenter: Magdalena Meissner
Session: Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications
Resources:
Webcast
Optimising 1L treatment in clinical practice
Presenter: Tony S.K. Mok
Session: Pfizer Oncology - Setting a new benchmark for ALK+ aNSCLC targeted therapy
Resources:
Webcast
Selectively targeting HER2 in NSCLC
Presenter: Jon Zugazagoitia
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast
Improving Joint Decision Making in Genitourinary Cancers
Presenter: Michael Jewett
Session: Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC
Resources:
Webcast
Added value of Liquid Biopsy testing in advanced cancer – IMPRESS NORWAY
Presenter: Åslaug Helland
Session: Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications
Resources:
Webcast
Practical strategies for managing adverse events
Presenter: Enriqueta Felip
Session: Pfizer Oncology - Setting a new benchmark for ALK+ aNSCLC targeted therapy
Resources:
Webcast
Panel discussion and audience Q&A
Presenter: Martin Wermke, Gerrina Ruiter, Jon Zugazagoitia
Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?
Resources:
Webcast